Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
76
-
Total shares
-
24.3M
-
Shares change
-
-3.72M
-
Total reported value, excl. options
-
$51.9M
-
Value change
-
-$10.5M
-
Put/Call ratio
-
1.85
-
Number of buys
-
39
-
Number of sells
-
-27
-
Price
-
$2.14
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q3 2019
79 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q3 2019.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.3M shares
.
Largest 10 shareholders include BlackRock Inc. (8.1M shares), VANGUARD GROUP INC (5.13M shares), STATE STREET CORP (2.27M shares), GEODE CAPITAL MANAGEMENT, LLC (1.56M shares), NORTHERN TRUST CORP (1.5M shares), Nuveen Asset Management, LLC (542K shares), Bank of New York Mellon Corp (433K shares), CITADEL ADVISORS LLC (299K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (293K shares), and BANK OF AMERICA CORP /DE/ (222K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.